Drug Evaluation Committee Papers on eConsent Practices and Problem-Solving Strategies
Electronic Standard for Medical Information Expert Committee
August 2023
In January 2022, an online survey on eConsent was conducted among Japan Pharmaceutical Manufacturers Association member companies by the International Trials Department of the National Center for Global Health and Medicine.
Based on the results of the survey, a paper on eConsent practices and measures to resolve issues was discussed, and the International Trials Department of the NIH and Electronic Standard for Medical Information Expert CommitteeTF3 jointly wrote the paper, which has now been submitted, accepted, and published in GHM Open.
▼ Published on J-stage
In addition to providing feedback to the Japan Pharmaceutical Manufacturers Association member companies that responded to our survey, we hope that this publication will promote discussion of eConsent among not only pharmaceutical companies but also other parties involved in clinical trials, and promote more patient-centered clinical trials.
We hope that this publication will help improve the efficiency of clinical trials and promote eConsent in the pharmaceutical industry.
Japan Pharmaceutical Manufacturers Association Drug Evaluation Committee
Electronic Standard for Medical Information Expert Committee 2023 Task Force 3